PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France. Electronic address: franck.touret@univ-amu.fr.\', \'Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.\', \'Cancer Center of Bordeaux, Institut Bergonié, INSERM U1218, University of Bordeaux, Bordeaux, France.\', \'Department for Infectious and Tropical Diseases, University Hospital Center of Bordeaux, Bordeaux, France; Inserm 1219, University of Bordeaux, Bordeaux, France.\', \'APHM, Unité des Virus Émergents (UVE: Aix Marseille University IRD 190-Inserm 1207-IHU Méditerranée Infection), Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(21)00127-310.1016/j.antiviral.2021.105137
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 34265358
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34265358>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34265358>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all